Qingdao Api&Herb Biopharm Co.,Ltd.
Qingdao Api&Herb Biopharm Co., Ltd. is located in Qingdao, Shandong Province, near the Tsingtao port, positioning the company in a region with access to international logistics routes. The firm identifies itself as a leading manufacturer of plant extracts and provides original equipment manufacturing (OEM) services for capsules and tablets. The emphasis placed on product quality reflects the company’s stated commitment to serving its customers as a core belief. Over its period of development, Api&Herb Biopharm has aimed to establish reliable, long-term relationships with diverse partners around the world, underscoring its intent to support global customers with its pharmaceutical-grade solutions.
The company presents itself as a provider of specialized services within the pharmaceutical and nutraceutical space, focusing on the production of plant-based extracts and the formulation and manufacture of finished dosage forms such as capsules and tablets. While further technical details are not included in the available material, the profile suggests a strategic orientation toward quality assurance, consistent supply, and customer-focused service.
Because the available information is limited, this profile emphasizes verifiable aspects: geographic location in Qingdao, proximity to a major port for potential export activities, a stated focus on plant extract products, and capabilities in OEM manufacturing for capsules and tablets. The description also notes a commitment to innovation as part of its ongoing business development. Organizations looking for manufacturing partners in China with experience in plant-derived ingredients and contract manufacturing for dosage forms may consider Api&Herb Biopharm as a potential candidate, subject to further due diligence and supplier qualification checks.
In terms of potential capabilities and collaboration avenues, clients might expect basic aspects such as raw material processing, standardization of plant extracts, formulation support for capsule and tablet products, and adherence to quality management systems typical of pharmaceutical manufacturing. The firm’s stated international orientation—developing cooperation with global customers—suggests that Api&Herb Biopharm is open to export-oriented projects and cross-border supply chain configurations. Prospective partners are advised to engage directly to gather detailed information on regulatory compliance, quality certifications, production capacity, lead times, and a broader array of contract manufacturing services that may extend beyond the scope of the available public materials.
Overall, Qingdao Api&Herb Biopharm Co., Ltd. presents itself as a China-based manufacturer of plant extracts with OEM capabilities for capsules and tablets. While the concise company profile highlights a quality-centric approach and a global partnership mindset, additional documentation would be necessary to fully assess manufacturing scale, regulatory status, testing protocols, and the breadth of product categories offered. For directory readers, Api&Herb Biopharm stands as a potential partner within the Chinese pharmaceutical supply chain, particularly for clients seeking plant-derived ingredient solutions coupled with contract manufacturing for solid dosage forms.
